Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. (Q31383623)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 July 2017

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. (English)

1 reference

Europe PubMed Central

1 July 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

6

object named as

A J Camm

1 reference

Europe PubMed Central

1 July 2017

author name string

B Pitt

1

1 reference

Europe PubMed Central

1 July 2017

P A Poole-Wilson

2

1 reference

Europe PubMed Central

1 July 2017

R Segal

3

1 reference

Europe PubMed Central

1 July 2017

F A Martinez

4

1 reference

Europe PubMed Central

1 July 2017

K Dickstein

5

1 reference

Europe PubMed Central

1 July 2017

M A Konstam

7

1 reference

Europe PubMed Central

1 July 2017

G Riegger

8

1 reference

Europe PubMed Central

1 July 2017

G H Klinger

9

1 reference

Europe PubMed Central

1 July 2017

J Neaton

10

1 reference

Europe PubMed Central

1 July 2017

D Sharma

11

1 reference

Europe PubMed Central

1 July 2017

B Thiyagarajan

12

1 reference

Europe PubMed Central

1 July 2017

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

1 July 2017

1 reference

Europe PubMed Central

1 July 2017

355

1 reference

Europe PubMed Central

1 July 2017

1582-1587

1 reference

Europe PubMed Central

1 July 2017

9215

1 reference

Europe PubMed Central

1 July 2017

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of heart failure: The Task Force of the Working Group on Heart Failure of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The management of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary care physicians: champions of or an impediment to optimal care of the patient with heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-Converting Enzyme Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental evidence to support ELITE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II-forming pathways in normal and failing human hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiarrhythmic effects of ACE inhibitors: a matter of faith or reality?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of long-term ventricular arrhythmia reduction by enalapril in heart failure. SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan and captopril on QT dispersion in elderly patients with heart failure. ELITE study group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional impact of an increase in ventricular mass after myocardial damage and its attenuation by converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

ABC of heart failure. Management: diuretics, ACE inhibitors, and nitrates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902213-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)02213-3

1 reference

Europe PubMed Central

1 July 2017

1 reference

Europe PubMed Central

1 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31383623&oldid=1582922928"